Cell killing action of cell cycle phase-non-specific antitumor agents is dependent on concentration-time product
- 1 May 1988
- journal article
- research article
- Published by Springer Nature in Cancer Chemotherapy and Pharmacology
- Vol. 21 (3) , 185-190
- https://doi.org/10.1007/bf00262767
Abstract
Based on a pharmacokinetic model proposed by Jusko, which assumes that the cell killing action of cell cycle phase-non-specific agents occurs as a bimolecular reaction depending on drug concentration and cell density, we derived a cell kill kinetic equation for these drugs, including the decomposition constant in culture medium. This equation revealed that the cell killing activity of these drugs depends on the value of concentration x exposure time or the area under the drug concentration-time curve (AUC). It was also clarified that the curves for concentration-exposure time necessary for 90% cell kill on a log scale simulated on the basis of the equation differ according as whether drugs are stable or unstable in the culture medium, being expected to be linear with a slope of-1 in the former case, and to take the form of an asymptotic curve in the latter. For three cell cycle phase-non-specific agents, mitomycin C (MMC), 1-(4-amino-2-methylpyrimidine-5-yl)-methyl-3-(2-chloroethyl)3-nitrosourea hydrochloride (ACNU), and nitrogen mustard (HN2), we assessed the concentrations necessary for 90% cell kill (IC90) with various exposure times and the degradation rate constants under the culture conditions used. MMC was quite stable during the incubation, while ACNU and HN2 were unstable. When IC90's and exposure times were plotted on the above-mentioned graph, a linear relationship with a slope of-1 was seen for MMC, while for ACNU and HN2 the anticipated asymptotic curves resulted. We also ascertained that the decomposition constants for ACNU and HN2 expected on the basis of these curves showed a good agreement with the corresponding experimentally observed values. These results indicate that the cell killing action of cell cycle phase-non-specific drugs can be well described by a pharmacodynamic model and equation employing their decomposition constants and are dependent on the concentration-time product.Keywords
This publication has 11 references indexed in Scilit:
- Dosage Regimen Design for Pharmaceutical Studies Conducted in AnimalsJournal of Pharmaceutical Sciences, 1986
- Clinical anticancer pharmacology: Some pharmacokinetic considerationsCancer Treatment Reviews, 1986
- Anticancer drug pharmacodynamicsCancer Chemotherapy and Pharmacology, 1985
- Metabolic activation of mitomycin C by liver microsomes and nucleiBiochemical Pharmacology, 1982
- Anticancer Drugs: Effect on the Cloning of Raji Lymphoma Cells in Soft AgarJNCI Journal of the National Cancer Institute, 1982
- QUANTITATIVE DOSE-RESPONSE RELATIONS FOR THE CYTO-TOXIC ACTIVITY OF CHLOROETHYLNITROSOUREAS IN CELL-CULTURE1982
- A pharmacokinetic analysis program (multi) for microcomputer.Journal of Pharmacobio-Dynamics, 1981
- Interrelationships of some chemical, physicochemical, and biological activities of several 1-(2-haloethyl)-1-nitrosoureas.1974
- Quantitative clonal growth of mammalian cells: its application for quantitative study of cytocidal action of Mitomycin-C.1972
- Pharmacodynamics of Chemotherapeutic Effects: Dose-Time-Response Relationships for Phase-Nonspecific AgentsJournal of Pharmaceutical Sciences, 1971